Effect of corticotherapy on proteomics of endometrial fluid from mares susceptible to persistent postbreeding endometritis.
The objective was to determine the effects of corticotherapy, in the presence and absence of uterine inflammation, on proteomics of endometrial fluid from mares susceptible to endometritis. In 11 mares, estrus was induced seven times with 5 mg PGF(2α) given at 14-day intervals. The first estrus was a control (no treatment). During the third estrus, mares received glucocorticoid (GC) treatment (20 mg isoflupredone acetate) every 12 h, for three consecutive days. The fifth estrus was the Infected treatment (intrauterine infusion of 1 × 10(9) colony-forming unit/mL Streptococcus equi subspecies zooepidemicus). Finally, the seventh was a combination of GC + Infected treatment (infusion of bacteria 24 h after the first GC treatment). At 12 h after the end of each treatment, uterine samples were collected and submitted to two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) for protein separation and mass spectrometry. Both GC treatment and uterine lumen infection induced proteomic alterations in the endometrial fluid of susceptible mares, characterized by an increase, decrease, or both in the relative optic density and/or frequency of inflammatory acute phase proteins (APP), with major alterations occurring when corticotherapy was applied in the presence of an infectious process. Corticotherapy in the presence of infection increased α(1)-antitrypsin (AAT), transthyretin (TT), and actin, but reduced immunoglobulin G, whereas intrauterine infection increased haptoglobin (Hp) and apolipoprotein A-1 (ApoA-1) and decreased transferrin (TF). Infection reduced levels of α(1)-antitrypsin and transthyretin, whereas corticotherapy in the presence of infection increased their frequency. We concluded that GC influenced the immune response, not only as suppressors, but also as enhancers of local defense mechanisms, through an immunomodulatory action. Short-term corticotherapy could be beneficial for treatment of uterine infectious processes in the mare.
REPROLAB, Veterinary Faculty, University of Rio Grande do Sul, Brazil. cvetwolf@yahoo.com.br
C A
CA
Wolf
E
E
Maslchitzky
R M
RM
Gregory
M I M
MI
Jobim
R C
RC
Mattos
D000209:Acute-Phase Proteins / Q000378:metabolism; D000818:Animals; D016632:Apolipoprotein A-I / Q000378:metabolism; D004198:Disease Susceptibility / Q000662:veterinary; D004716:Endometritis / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005477:Fluprednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use*; D006734:Horse Diseases / Q000188:drug therapy* / Q000382:microbiology; D006736:Horses; D040901:Proteomics; D018502:Streptococcus equi; D014168:Transferrin / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000378:metabolism
D000209:Acute-Phase Proteins; D016632:Apolipoprotein A-I; D005938:Glucocorticoids; D014168:Transferrin; D000515:alpha 1-Antitrypsin; C065592:isoflupredone acetate; D005477:Fluprednisolone